Special: Warren Buffett Was WRONG on This One… Time for YOU to Profit!



EDIT: Editas Medicine is a Sell

The current rating for EDIT is 35, which is 43% below its historic median rating of 50. This indicates higher risk than normal.

The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.